glp 1 investing research2guidance GLP-1 Lasting Outcomes

Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance

In February, FDA announced a crackdown on misleading marketing

These are no longer endocrinology or primary care drugs

While both are classified as research peptides used in laboratory studies , they differ significantly in receptor targeting and signaling behavior

Hair loss has also been reported, likely related to rapid weight loss rather than the medication itself

Blood sugar support supports healthy blood sugar levels and helps reduce HbA1c